Exploring recent advances in senolytic and senomorphic therapies, including dasatinib-quercetin and immune-based approaches, to combat age-related diseases like Alzheimer’s and sarcopenia. New t...
Recent studies reveal that supplementing Roseburia inulinivorans enhances muscle strength by up to 30% in mice, with human trials showing promise for probiotic therapies against sarcopenia. New resear...
Emerging research shows that enhancing mRNA surveillance mechanisms like nonsense-mediated decay can reduce neurodegeneration, with innovative therapies targeting tau aggregation offering new hope. Re...
Recent studies uncover autophagy’s dual role in aging, suggesting early enhancement through lifestyle may delay decline, while late-stage inhibition in senescent cells could reduce inflammation,...
Recent studies on hydra’s negligible senescence overturn traditional aging models, suggesting aging is adaptable and offering clues for anti-aging biotech interventions. New research reveals hyd...
Recent research shows lipid nanoparticles delivering mRNA can reduce tau protein aggregates in Alzheimer’s models, with Moderna advancing clinical trials and regulatory support accelerating deve...
Recent studies highlight autophagy’s conflicting roles in aging: protective early on but sustaining harmful senescent cells under stress, with the threshold model guiding new clinical approaches...
Recent studies from the LEV Foundation and Brian Kennedy’s team show that combining therapies targeting multiple age-related damages can significantly extend lifespan and healthspan in preclinic...
Recent studies reveal aging microglia can promote amyloid-β aggregation, shifting Alzheimer’s pathology understanding and highlighting new therapeutic strategies targeting immune-brain interact...
Recent studies show Roseburia inulinivorans boosts muscle strength in aging, with probiotics targeting sarcopenia gaining traction in the wellness market amid regulatory and ethical debates. Breakthro...
